Severe Epistaxis after Tissue Plasminogen Activator administration for Acute Ischemic Stroke in SARS...
Severe Epistaxis after Tissue Plasminogen Activator administration for Acute Ischemic Stroke in SARS-COV-2 Infection
About this item
Full title
Author / Creator
Publisher
Mumbai: Wolters Kluwer India Pvt. Ltd
Journal title
Language
English
Formats
Publication information
Publisher
Mumbai: Wolters Kluwer India Pvt. Ltd
Subjects
More information
Scope and Contents
Contents
Patients with COVID-19 may suffer from hemorrhagic complications. Our article highlights two cases of COVID-19-infected patients, who suffered severe epistaxis after initiation of intravenous recombinant tissue plasminogen activator (IV-rtPA) for acute ischemic stroke, followed by a sudden decline in their clinical status and ultimately leading to...
Alternative Titles
Full title
Severe Epistaxis after Tissue Plasminogen Activator administration for Acute Ischemic Stroke in SARS-COV-2 Infection
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_acf288d5645140aabd8f71bcfbc28de5
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_acf288d5645140aabd8f71bcfbc28de5
Other Identifiers
ISSN
2394-8108,2455-4626
E-ISSN
2455-4626
DOI
10.4103/bc.bc_17_21
